| MERA medication class | No. of times MERA team recommended discontinuation (% of all recommended discontinuations), n = 201 | No. of patients in whom medication class was recommended to be stopped (% of all patients enrolled), n = 53 |
|---|---|---|
| Vitamins/minerals | 55 (27) | 28 (53) |
| Lipid-lowering agents | 20 (10) | 20 (38) |
| Homeopathic/herbal supplements | 14 (7) | 6 (11) |
| Proton pump inhibitors | 13 (6) | 13 (25) |
| Docusate | 8 (4) | 8 (15) |
| Antiplatelet agents | 7 (3) | 7 (13) |
| Benzodiazepines | 6 (3) | 6 (11) |
| Bisphosphonates (oral) | 5 (2) | 5 (9) |
| Dihydropyridine calcium-channel blockers | 5 (2) | 5 (9) |
| Opioids | 5 (2) | 5 (9) |
| Acetaminophen | 4 (2) | 4 (8) |
| Iron (oral) | 4 (2) | 4 (8) |
| Nonbenzodiazepine hypnotics | 4 (2) | 4 (8) |
| Thiazide diuretics | 4 (2) | 4 (8) |
Note: MERA = Medication Rationalization.